Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000475811 | SCV000563897 | pathogenic | Lynch syndrome | 2016-11-06 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 4-16 of the MSH2 gene. The 5' boundary is likely confined to intron 4. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated MSH2 protein. Gross deletions in MSH2 are known to be pathogenic (PMID: 15849733, 24362816). A similar deletion of exons 4-16 has been reported in individuals affected with colorectal cancer (PMID: 15713769, 22776989). For these reasons, this variant has been classified as Pathogenic. |